1. |
Cuypers JA, Menting ME, Konings EE, et al. Unnatural history of tetralogy of Fallot: Prospective follow-up of 40 years after surgical correction. Circulation, 2014, 130(22): 1944-1953.
|
2. |
Ali LA, Gentili F, Festa P, et al. Long-term assessment of clinical outcomes and disease progression in patients with corrected tetralogy of Fallot. Eur Rev Med Pharmacol Sci, 2021, 25(20): 6300-6310.
|
3. |
Ansari MM, Cardoso R, Garcia D, et al. Percutaneous pulmonary valve implantation: Present status and evolving future. J Am Coll Cardiol, 2015, 66(20): 2246-2455.
|
4. |
潘文志, 周达新, 葛均波. 经皮肺动脉瓣植入术的研究进展. 中国医学前沿杂志(电子版), 2013, 5(6): 24-28.Pan WZ, Zhou DX, Ge JB. Research progress on percutaneous pulmonary valve implantation. Chin J Front Med Sci (Electronic Version), 2013, 5(6): 24-28.
|
5. |
陈峰, 李红梅, 沈立. 法洛四联症根治术后肺动脉瓣置换术研究进展. 中华小儿外科杂志, 2020, 41(1): 5.Chen F, Li HM, Shen L. Research progress on pulmonary valve replacement after radical surgery for tetralogy of Fallot. Chin J Pediatr Surg, 2020, 41(1): 5.
|
6. |
Kenny D, Hijazi ZM, Kar S, et al. Percutaneous implantation of the Edwards SAPIEN transcatheter heart valve for conduit failure in the pulmonary position: Early phase 1 results from an international multicenter clinical trial. J Am Coll Cardiol, 2011, 58(21): 2248-2256.
|
7. |
Priromprintr B, Silka MJ, Rhodes J, et al. A prospective 5-year study of exercise performance following Melody valve implant. Am Heart J, 2019, 209: 47-53.
|
8. |
Martin MH, Meadows J, McElhinney DB, et al. Safety and feasibility of melody transcatheter pulmonary valve replacement in the native right ventricular outflow tract: A multicenter pediatric heart network scholar study. JACC Cardiovasc Interv, 2018, 11(16): 1642-1650.
|
9. |
Lurz P, Kister T. Why we need another percutaneous pulmonary valve: If size matters. EuroIntervention, 2019, 14(13): 1347-1349.
|
10. |
黄颖, 周子秦, 张勇, 等. 自膨式介入肺动脉瓣经胸植入术的早期结果. 中国胸心血管外科临床杂志, 2024, 31(6): 872-877.Huang Y, Zhou ZQ, Zhang Y, et al. Early outcomes of self-expanding interventional pulmonary valve in transthoracic implantation. Chin J Clin Thorac Cardiovasc Surg, 2024, 31(6): 872-877.
|
11. |
Zoghbi WA, Jone PN, Chamsi-pasha MA, et al. Guidelines for the evaluation of prosthetic valve function with cardiovascular imaging: A report From the American Society of Echocardiography Developed in collaboration with the Society for Cardiovascular Magnetic Resonance and the Society of Cardiovascular Computed Tomography. J Am Soc Echocardiogr, 2024, 37(1): 2-63.
|
12. |
Lee C, Choi ES, Lee CH. Long-term outcomes of pulmonary valve replacement in patients with repaired tetralogy of Fallot. Eur J Cardiothorac Surg, 2020, 58(2): 246-252.
|
13. |
Gillespie MJ, McElhinney DB, Jones TK, et al. 1-year outcomes in a pooled cohort of harmony transcatheter pulmonary valve clinical trial participants. JACC Cardiovasc Interv, 2023, 16(15): 1917-1928.
|
14. |
Qureshi AM, Bansal N, McElhinney DB, et al. Branch pulmonary artery valve implantation reduces pulmonary regurgitation and improves right ventricular size/function in patients with large right ventricular outflow tracts. JACC Cardiovasc Interv, 2018, 11(6): 541-550.
|
15. |
Kim GB, Song MK, Bae EJ, et al. Successful feasibility human trial of a new self-expandable percutaneous pulmonary valve (Pulsta valve) implantation using knitted nitinol wire backbone and trileaflet α-gal-free porcine pericardial valve in the native right ventricular outflow tract. Circ Cardiovasc Interv, 2018, 11(6): e006494.
|
16. |
Zhou D, Pan W, Jilaihawi H, et al. A self-expanding percutaneous valve for patients with pulmonary regurgitation and an enlarged native right ventricular outflow tract: One-year results. EuroIntervention, 2019, 14(13): 1371-1377.
|
17. |
Morgan G, Prachasilchai P, Promphan W, et al. Medium-term results of percutaneous pulmonary valve implantation using the Venus P-valve: International experience. EuroIntervention, 2019, 14(13): 1363-1370.
|
18. |
Virk SA, Liou K, Chandrakumar D, et al. Percutaneous pulmonary valve implantation: A systematic review of clinical outcomes. Int J Cardiol, 2015, 201: 487-489.
|
19. |
McElhinney DB, Cheatham JP, Jones TK, et al. Stent fracture, valve dysfunction, and right ventricular outflow tract reintervention after transcatheter pulmonary valve implantation: Patient-related and procedural risk factors in the US Melody valve tial. Circ Cardiovasc Interv, 2011, 4(6): 602-614.
|
20. |
McElhinney DB, Sondergaard L, Armstrong AK, et al. Endocarditis after transcatheter pulmonary valve replacement. J Am Coll Cardiol, 2018, 72(22): 2717-2728.
|
21. |
Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J, 2022, 43(7): 561-632.
|
22. |
Fraisse A, Aldebert P, Malekzadeh-Milani S, et al. Melody® transcatheter pulmonary valve implantation: Results from a French registry. Arch Cardiovasc Dis, 2014, 107(11): 607-614.
|